Plasma Products

  • Human Albumin

    Shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; prevention and treatment of low-density-lipoproteinemia; and Neonatal hyperbilirubinemia.

    Specifications: 10%: 20ml, 10% - 50ml, 10%: 100 ml, 20%: 10ml, 20%: 25ml, 20%: 50ml, and 25%: 50ml.

  • Human Immunoglobulin for Intravenous Injection

    Primary immunoglobulin deficiency, such as X chain low immunoglobulin, familiar variable immune deficiency, immunoglobulin G secondary deficiency; secondary immunoglobulin deficiency, such as severe infection, newborn sepsis; and auto-immune deficiency diseases, such as Idiopathic thrombocytopenia purpura or kawasaki disease.

    Specifications: 5%: 50ml and 5%: 100ml.

  • Human Hepatitis B Immunoglobulin

    Prevention of measles and contagious hepatitis. When applied together with antibiotics, its curative effect on certain severe bacteria or virus infection may be improved.

    Specifications: 100IU, 200IU, and 400IU.

  • Human Tetanus Immunoglobulin

    Mainly used for the prevention and therapy of tetanus. Particularly applied to patients who have allergic reactions to tetanus antitoxin.

    Specifications:250IU.

  • Human Rabies Immunoglobulin

    Mainly for passive immunity from bites or claws by rabies or other infected animals. All patients suspected of being exposed to rabies will be treated with a combined dose of rabies vaccine and human rabies immunoglobulin.

    Specifications: 100IU, 200IU, and 500IU.

  • Human Immunoglobulin

    Primary immunoglobulin deficiency, such as X chain low immunoglobulin, familiar variable immune deficiency, immunoglobulin G secondary deficiency; secondary immunoglobulin deficiency, such as severe infection, newborn sepsis; and auto-immune deficiency diseases, such as Idiopathic thrombocytopenia purpura or kawasaki disease.

    Specifications: 10%: 3ml and 10%: 1.5ml.

  • Human Coagulation Factor VIII

    Correcting the disorder of coagulation due to deficiency of Factor VIII ,mainly for prevention and control of bleeding in patients with hemophilia A or acquired Factor VIII deficiency ,and for treatment of bleeding caused by operation of these patients.

    Specifications: 200IU 300IU

  • Human Prothrombin Complex Concentrate

    This product is mainly used for the treatment of congenital and acquired clotting factor II, VII, IX, X deficiency (single deficiency or combined deficiency), including: the clotting factor II, VII, IX, X deficiency, including Hemophilia B; Excessive anticoagulant, and vitamin K deficiency; the mechanism of coagulation disorders and bleeding caused by liver disease when the patients need to correct blood coagulation dysfunction; a variety of reasons caused by the prothrombin time prolong and the patients intend to go for surgery, but the lack of clotting factor may be rejected; treatment for the bleeding symptoms of Hemophilia A who has produced inhibitor of clotting factor VIII; reversing hemorrhage induced by coumarin anticoagulants.

    Specifications: 300IU

  • Human Fibrinogen

    Mainly used to treat: (a) congenital fibrinogen reduction or deficiency and (b) acquired fibrinogen deficiency associated with serious liver damage, cirrhosis, disseminated intravascular coagulation, or coagulation disorder resulting from the lack of fibrinogen related to postpartum hemorrhage, major surgery, trauma, or acute bleeding.

    Specifications: 0.5g

© 2018 China Biologic Products Holdings, Inc. All Rights Reserved.